跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
APO-PRAMIPEXOLE pramipexole dihydrochloride monohydrate 1 mg tablet blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
APO-PRAMIPEXOLE pramipexole dihydrochloride monohydrate 1 mg tablet blister pack
Approved
STANDARD
APO-PRAMIPEXOLE pramipexole dihydrochloride monohydrate 1 mg tablet blister pack
Southern Cross Pharma Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
d6c999e4a995a9a3
Company
Southern Cross Pharma Pty Ltd
Type
Standard
Approval Details
Approval Id
d6c999e4a995a9a3
Product Name
APO-PRAMIPEXOLE pramipexole dihydrochloride monohydrate 1 mg tablet blister pack
Artg Id
227669
Artg Name
APO-PRAMIPEXOLE pramipexole dihydrochloride monohydrate 1 mg tablet blister pack
Sponsor
Southern Cross Pharma Pty Ltd
Company Detail Path
/organization/southern-cross-pharma-pty-ltd
Artg Date
2015-11-17
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/91952c063bf95041eec0aee12da5f438.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/dd852559af8dd0a929c28c0285ef6599.pdf
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
d6c999e4a995a9a3
Type
Standard
Back to TGA Approvals